期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

芳香化酶抑制剂相关骨关节症状治疗现状 被引量：1

原文传递
导出
摘要 芳香化酶抑制剂（aromatase inhibitor，AI）作为内分泌治疗的一种药物，广泛应用于绝经后激素依赖型乳腺癌患者的治疗中。
作者 吴敏 陆启滨 彭楠 王笑民
机构地区 不详 首都医科大学附属北京中医医院肿瘤科
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2014年第1期109-112,共4页 Chinese Journal of Integrated Traditional and Western Medicine
基金 北京市科学技术委员会项目(No.D13110700220000)
关键词 芳香化酶抑制剂 症状治疗 骨关节 内分泌治疗 乳腺癌患者 激素依赖型 绝经后
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献27

  • 1Howell A,Cuzick J,Baum M. Results of the ATAC (Arimidex,Tamoxifen,alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer[J].{H}LANCET,2005,(9453):60-62.
  • 2Thurlimann B,Keshaviah A,Coates AS. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer[J].{H}New England Journal of Medicine,2005,(26):2747-2757.
  • 3Coombes RC,Kilburn LS,Snowdon CF. Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study):a randomized controlled trial[J].{H}LANCET,2007,(9561):559-570.
  • 4Boccardo F,Rubagotti A,Guglielmini P. Switching to anastrozole versus continued tamoxifen treatment of early breast cancer.Updated results of the Italian tamoxifen anastrozole (ITA)trial[J].{H}ANNALS OF ONCOLOGY,2006,(Suppl 7):i10-i14.
  • 5Jakesz R,Jonat W,Gnant M. Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2years' adjuvant tamoxifen:combined results of ABCSG trial 8 and ARNO 95 trial[J].{H}LANCET,2005,(9484):455-462.
  • 6Goss PE,Ingle JN,Martino S. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer[J].{H}New England Journal of Medicine,2003,(19):1793-1802.
  • 7Crew KD,Greenlee H,Capodice J. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for earlystage breast cancer[J].{H}Journal of Clinical Oncology,2007,(25):3877-3883.
  • 8Henry NL,Giles JT,Ang D. Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors[J].{H}Breast Cancer Research and Treatment,2008,(2):365-372.
  • 9Mieog JS,Morden JP,Bliss JM. Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3years of tamoxifen:a retrospective analysis of the Intergroup Exemestane Study[J].{H}LANCET ONCOLOGY,2012,(4):420-432.
  • 10Niravath P. Aromatase inhibitor-induced arthralgia:a review[J].{H}ANNALS OF ONCOLOGY,2013,(Suppl 7):i15-i17.

二级参考文献2

  • 1Buzdar AU, Guastalla JP, Nabholtz J, et al. Impact of chemotherapy regimensprior to endocrine therapy. Cancer, 2006, 107 ( 3 ) : 472.
  • 2Hadji R. Aromatase inhibitor - associated bone loss in breast cancer patients is distinct from postmenopausal osteoporsis. Crit Rev Oncol Hematol,2009,69( 1 ) :73.

共引文献4

同被引文献24

引证文献1

二级引证文献2

中国中西医结合杂志
2014年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部